Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)

Journal

Annals of the Rheumatic Diseases

Journal Volume

79

Journal Issue

2

Start Page

176-185

ISSN

0003-4967

Date Issued

2020-02

Author(s)

Maxime Dougados

Robert Landewé

Joachim Sieper

Xenofon Baraliakos

Filip Van den Bosch

Walter P Maksymowych

Joerg Ermann

Jessica A Walsh

Tetsuya Tomita

Atul Deodhar

Désirée van der Heijde

Xiaoqi Li

Fangyi Zhao

Clinton C Bertram

Gaia Gallo

Hilde Carlier

Lianne S Gensler

DOI

URI

Publisher

Elsevier BV

Type

journal-article